Patents by Inventor Yuguo ZHENG

Yuguo ZHENG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210009981
    Abstract: The present invention discloses a nitrilase mutant and its construction method and its application in the synthesis of chiral intermediate of pregabalin in the technical field of bioengineering. The present invention, respectively, takes turnip nitrilase BrNIT and arabidopsis nitrilase AtNIT as parent, using peptide fragment displacement method, displaces the sites 226-286 of BrNIT amino acid sequence and sites 225-285 of AtNIT amino acid sequence with sites 225-285 of Arabis alpina L. nitrilase AaNIT, obtain nitrilase mutants BrNIT225-285 and AtNIT225-285 of which the amino acid sequence is as shown in SEQ ID NO.1 or SEQ ID NO.3.
    Type: Application
    Filed: January 31, 2019
    Publication date: January 14, 2021
    Inventors: RENCHAO ZHENG, YUGUO ZHENG, QIN ZHANG, ZHEMING WU, XIAOLING TANG, XIAFENG LU
  • Publication number: 20200115695
    Abstract: The present invention discloses a nitrilase mutant and application thereof. The mutant is obtained by mutating the amino acid at position 201 or replacing one or more amino acids at region 324-381 of the amino acid sequence shown in SEQ ID No. 2. In the present invention, by the protein molecular modification, thermostability of the purified nitrilase LNIT5 is increased by up to 4.5 folds; and by utilizing recombinant E. coli containing the nitrilase mutant to hydrolyze 1-cyanocyclohexylacetonitrile at a high temperature (45° C.), product tolerance is increased, activity of NIT5-L201F is increased by 20%, and the mutant NITLNIT5-AcN can completely hydrolyze 750 mM 1-cyanocyclohexylacetonitrile within 8 hours and achieve an doubled conversion rate. Therefore, the mutants obtained by the present invention have a good application prospect in efficiently catalyzing 1-cyanocyclohexylacetonitrile to synthesize gabapentin intermediate, 1-cyanocyclohexyl acetic acid.
    Type: Application
    Filed: January 24, 2019
    Publication date: April 16, 2020
    Inventors: Yaping XUE, Yuguo ZHENG, Zhe XU, Zhiqiang LIU
  • Patent number: 10260059
    Abstract: The disclosure provides a nitrilase from Arabis alpina, which belongs to genus Arabis, family brassicaceae. The disclosure further provides the encoding gene, vector, recombinant bacterial strain, and the application in the manufacturing of (S)-3-cyano-5-methylhexanoic acid. The wet resting cells containing nitrilase Aa-Nit can kinetically resolve racemic IBSN at 1.2 M with a 42% conversion rate in 15 hr and >99% ee value. The disclosure provides a regio- and stereoselective method for the preparation of (S)-3-cyano-5-methylhexanoic acid. This method provides an atom economical, mild, environmental friendly industrial method to manufacture (S)-3-cyano-5-methylhexanoic acid.
    Type: Grant
    Filed: August 28, 2017
    Date of Patent: April 16, 2019
    Assignees: Zhejiang University of Technology, Zhejiang Chiral Medicine Chemicals Co. Ltd.
    Inventors: Renchao Zheng, Yuguo Zheng, Qin Zhang, Youming Huang, Jianfeng Weng, Tianchun Liu, Weirong Fan
  • Patent number: 10100297
    Abstract: The disclosure provides a nitrilase from Arabis alpina, which belongs to genus Arabis, family brassicaceae. The disclosure further provides the encoding gene, vector, recombinant bacterial strain, and the application in the manufacturing of (S)-3-cyano-5-methylhexanoic acid. The wet resting cells containing nitrilase Aa-Nit can kinetically resolve racemic IBSN at 1.2 M with a 42% conversion rate in 15 hr and >99% ee value. The disclosure provides a regio- and stereoselective method for the preparation of (S)-3-cyano-5-methylhexanoic acid. This method provides an atom economical, mild, environmental friendly industrial method to manufacture (S)-3-cyano-5-methylhexanoic acid.
    Type: Grant
    Filed: August 28, 2017
    Date of Patent: October 16, 2018
    Assignees: ZHEJIANG CHIRAL MEDICINE CHEMICALS CO. LTD., ZHEJIANG UNIVERSITY OF TECHNOLOGY
    Inventors: Renchao Zheng, Yuguo Zheng, Qin Zhang, Youming Huang, Jianfeng Weng, Tianchun Liu, Weirong Fan
  • Publication number: 20170355976
    Abstract: The disclosure provides a nitrilase from Arabis alpina, which belongs to genus Arabis, family brassicaceae. The disclosure further provides the encoding gene, vector, recombinant bacterial strain, and the application in the manufacturing of (S)-3-cyano-5-methylhexanoic acid. The wet resting cells containing nitrilase Aa-Nit can kinetically resolve racemic IBSN at 1.2 M with a 42% conversion rate in 15 hr and >99% ee value. The disclosure provides a regio- and stereoselective method for the preparation of (S)-3-cyano-5-methylhexanoic acid. This method provides an atom economical, mild, environmental friendly industrial method to manufacture (S)-3-cyano-5-methylhexanoic acid.
    Type: Application
    Filed: August 28, 2017
    Publication date: December 14, 2017
    Applicants: Zhejiang University of Technology, Zhejiang Chiral Medicine Chemicals Co. Ltd.
    Inventors: Renchao ZHENG, Yuguo ZHENG, Qin ZHANG, Youming HUANG, Jianfeng WENG, Tianchun LIU, Weirong FAN
  • Publication number: 20170355975
    Abstract: The disclosure provides a nitrilase from Arabis alpina, which belongs to genus Arabis, family brassicaceae. The disclosure further provides the encoding gene, vector, recombinant bacterial strain, and the application in the manufacturing of (S)-3-cyano-5-methylhexanoic acid. The wet resting cells containing nitrilase Aa-Nit can kinetically resolve racemic IBSN at 1.2 M with a 42% conversion rate in 15 hr and >99% ee value. The disclosure provides a regio- and stereoselective method for the preparation of (S)-3-cyano-5-methylhexanoic acid. This method provides an atom economical, mild, environmental friendly industrial method to manufacture (S)-3-cyano-5-methylhexanoic acid.
    Type: Application
    Filed: August 28, 2017
    Publication date: December 14, 2017
    Applicants: Zhejiang University of Technology, Zhejiang Chiral Medicine Chemicals Co. Ltd.
    Inventors: Renchao ZHENG, Yuguo ZHENG, Qin ZHANG, Youming HUANG, Jianfeng WENG, Tianchun LIU, Weirong FAN
  • Publication number: 20170058274
    Abstract: The disclosure provides a nitrilase from Arabis alpina, which belongs to genus Arabis, family brassicaceae. The disclosure further provides the encoding gene, vector, recombinant bacterial strain, and the application in the manufacturing of (S)-3-cyano-5-methylhexanoic acid. The wet resting cells containing nitrilase Aa-Nit can kinetically resolve racemic IBSN at 1.2 M with a 42% conversion rate in 15 hr and >99% ee value. The disclosure provides a regio- and stereoselective method for the preparation of (S)-3-cyano-5-methylhexanoic acid. This method provides an atom economical, mild, environmental friendly industrial method to manufacture (S)-3-cyano-5-methylhexanoic acid.
    Type: Application
    Filed: August 25, 2016
    Publication date: March 2, 2017
    Applicants: Zhejiang University of Technology, Zhejiang Chiral Medicine Chemicals Co. Ltd.
    Inventors: Renchao ZHENG, Yuguo ZHENG, Qin ZHANG, Youming HUANG, Jianfeng WENG, Tianchun LIU, Weirong FAN